Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Chang

Showing results (121-130 of 224) with videos related to

Pageof 23
Sort By:
Annals of Surgical Oncology|March 14, 2014
High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapyJason Chia-Hsien Cheng, Madeline S Graber, Feng-Ming Hsu, et al.
American Journal of Clinical Oncology|June 6, 2019
Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon CancerJulie L Koenig, Diego A S Toesca, Jeremy P Harris, et al.
Rare Tumors|February 23, 2012
A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old maleStephen M Wanta, Marina Basina, Steven D Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2020
Intensified systemic therapy and stereotactic ablative radiotherapy dose for patients with unresectable pancreatic adenocarcinomaDiego A S Toesca, Faisal Ahmed, Mehr Kashyap, et al.
Nature Communications|March 26, 2021
Predicting treatment response from longitudinal images using multi-task deep learningCheng Jin, Heng Yu, Jia Ke, et al.
Cancer|January 2, 2009
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreasDaniel T Chang, Devin Schellenberg, John Shen, et al.
Practical Radiation Oncology|March 10, 2017
Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PETDiego A S Toesca, Erqi L Pollom, Peter D Poullos, et al.
Annals of Surgical Oncology|September 27, 2023
Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant RadiationCaressa Hui, Agnes Ewongwo, Brianna Lau, et al.
Expert Review of Anticancer Therapy|September 4, 2014
Stereotactic body radiation therapy in pancreatic cancer: the new frontierShalini Moningi, Ariel E Marciscano, Lauren M Rosati, et al.
Cancer|July 29, 2010
Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinomaDaniel T Chang, Christopher H Chapman, Jeffrey A Norton, et al.
Pageof 23

Showing results (121-130 of 224) with videos related to

Sort By:
Pageof 23
Annals of Surgical Oncology|March 14, 2014
High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapyJason Chia-Hsien Cheng, Madeline S Graber, Feng-Ming Hsu, et al.
American Journal of Clinical Oncology|June 6, 2019
Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon CancerJulie L Koenig, Diego A S Toesca, Jeremy P Harris, et al.
Rare Tumors|February 23, 2012
A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old maleStephen M Wanta, Marina Basina, Steven D Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2020
Intensified systemic therapy and stereotactic ablative radiotherapy dose for patients with unresectable pancreatic adenocarcinomaDiego A S Toesca, Faisal Ahmed, Mehr Kashyap, et al.
Nature Communications|March 26, 2021
Predicting treatment response from longitudinal images using multi-task deep learningCheng Jin, Heng Yu, Jia Ke, et al.
Cancer|January 2, 2009
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreasDaniel T Chang, Devin Schellenberg, John Shen, et al.
Practical Radiation Oncology|March 10, 2017
Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PETDiego A S Toesca, Erqi L Pollom, Peter D Poullos, et al.
Annals of Surgical Oncology|September 27, 2023
Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant RadiationCaressa Hui, Agnes Ewongwo, Brianna Lau, et al.
Expert Review of Anticancer Therapy|September 4, 2014
Stereotactic body radiation therapy in pancreatic cancer: the new frontierShalini Moningi, Ariel E Marciscano, Lauren M Rosati, et al.
Cancer|July 29, 2010
Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinomaDaniel T Chang, Christopher H Chapman, Jeffrey A Norton, et al.
Pageof 23